Trials / Not Yet Recruiting
Not Yet RecruitingNCT06608329
A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects
A Randomized, Open-label, Crossover Study to Evaluate Relative Bioavailability, and Food Effect of HDM1002 in Healthy Subjects
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 33 (estimated)
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of this study is to evaluate the effect of formulation on relative bioavailability of HDM1002, and the food effect on pharmacokinetics of HDM1002.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HDM1002 | Single dose, administered orally. The study is a randomized, open-label, single dose, 3-period, 3 sequence, crossover design. |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2024-11-01
- Completion
- 2024-12-01
- First posted
- 2024-09-23
- Last updated
- 2024-09-23
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06608329. Inclusion in this directory is not an endorsement.